Nitta Gelatin Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
2
Ending by 2030
Nov 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 23, 2026The maintenance fee for Therapeutic or preventive agent for diabetes (US 9,061,003) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Myoblast differentiation promoter (US 10,632,177) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Oct 6 US 12,751,908 Peptide Composition and Method for Producing Same
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,227,424 | Collagen peptide, dipeptide and malady inhibitor In force · USPTO record | In force | USPTO record | |
| US 8,410,062 | Collagen peptide, dipeptide and malady inhibitor In force · USPTO record | In force | USPTO record | |
| US 9,061,003 | Therapeutic or preventive agent for diabetes In force · USPTO record | In force | USPTO record | |
| US 10,660,345 | Pectin-Containing Acidic Milk Beverage and Production Method Thereof In force · High confidence | In force | High confidence | |
| US 10,632,177 | Myoblast differentiation promoter In force · USPTO record | In force | USPTO record | |
| US 10,815,393 | Gelatin, Chemically Modified Product Thereof, Aqueous Composition and Medical Laminate Containing Same, Production Method for Medical Laminate, and Cell Sheet Isolation Method In force · High confidence | In force | High confidence | |
| US 12,569,532 | Brain Function Regulating Agent, and Food or Beverage Product Containing Same In force · Medium confidence | In force | Medium confidence | |
| US 12,409,209 | Biological function regulating agent, epidermal metabolism promoting agent, fat accumulation inhibiting agent, fat decomposition promoting agent, adiponectin production promoting agent, functional food, cosmetic product, and method for producing biological function regulating agent In force · USPTO record | In force | USPTO record | |
| US 12,751,908 | Peptide Composition and Method for Producing Same In force · High confidence | In force | High confidence | |
| US 12,678,505 | Leakage Inhibiting Agent for Local Injection Preparation, Local Injection Preparation Including the Same, and Method for Producing Local Injection Preparation In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 1 patent in force now held by others · 5 lapsed for an unpaid fee · 12 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 abandoned · 10 no status recorded